1887

Abstract

GB virus C (GBV-C) is a non-pathogenic flavivirus that may play a role in modulating HIV disease. Multiple genotypes of GBV-C that have been identified to date that may differentially regulate HIV; however, the number of complete GBV-C sequences published to date is very limited. We sequenced full-length GBV-C genomes from four individuals with HIV/HCV co-infection in the United States. Intergenotypic recombination was evident in two of these individuals. Evaluation of additional full-length GBV-C genomes would facilitate the creation of full-length, replication-competent molecular clones of GBV-C to evaluate the phenotypic diversity of GBV-C genotypes and provide important molecular data on this understudied virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000477
2016-07-01
2020-04-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/7/1537.html?itemId=/content/journal/jgv/10.1099/jgv.0.000477&mimeType=html&fmt=ahah

References

  1. Alcalde R., Nishiya A., Casseb J., Inocêncio L., Fonseca L. A., Duarte A. J.. 2010; Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy. Virus Res151:148–152 [CrossRef][PubMed]
    [Google Scholar]
  2. Berzsenyi M. D., Bowden D. S., Roberts S. K.. 2005; GB virus C: insights into co-infection. J Clin Virol33:257–266 [CrossRef][PubMed]
    [Google Scholar]
  3. Berzsenyi M. D., Bowden D. S., Roberts S. K., Revill P. A.. 2009; GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease. J Gastroenterol Hepatol24:1407–1410 [CrossRef][PubMed]
    [Google Scholar]
  4. Birk M., Lindbäck S., Lidman C.. 2002; No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS16:2482–2485 [CrossRef][PubMed]
    [Google Scholar]
  5. Björkman P., Flamholc L., Nauclér A., Molnegren V., Wallmark E., Widell A.. 2004; GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS18:877–886 [CrossRef][PubMed]
    [Google Scholar]
  6. Blackard J. T., Cohen D. E., Mayer K. H.. 2002; Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis34:1108–1114 [CrossRef][PubMed]
    [Google Scholar]
  7. Chang Q., McLinden J. H., Stapleton J. T., Sathar M. A., Xiang J.. 2007; Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line. J Gen Virol88:3341–3346 [CrossRef][PubMed]
    [Google Scholar]
  8. Drummond A. J., Suchard M. A., Xie D., Rambaut A.. 2012; Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol29:1969–1973 [CrossRef][PubMed]
    [Google Scholar]
  9. Feng Y., Zhao W., Feng Y., Dai J., Li Z., Zhang X., Liu L., Bai J., Zhang H. et al. 2011; A novel genotype of GB virus C: its identification and predominance among injecting drug users in Yunnan, China. PLoS One6:e21151 [CrossRef][PubMed]
    [Google Scholar]
  10. Fogeda M., López-Alcorocho J. M., Bartolomé J., Arocena C., Martín M. A., Carreño V.. 2000; Existence of distinct GB virus C/hepatitis G virus variants with different tropism. J Virol74:7936–7942 [CrossRef][PubMed]
    [Google Scholar]
  11. George S. L., Xiang J., Stapleton J. T.. 2003; Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology316:191–201 [CrossRef]
    [Google Scholar]
  12. Katayama K., Kageyama T., Fukushi S., Hoshino F. B., Kurihara C., Ishiyama N., Okamura H., Oya A.. 1998; Full-length GBV-C/HGV genomes from nine Japanese isolates: characterization by comparative analyses. Arch Virol143:1063–1075 [CrossRef][PubMed]
    [Google Scholar]
  13. Kato T., Mizokami M., Nakano T., Orito E., Ohba K., Kondo Y., Tanaka Y., Ueda R., Mukaide M. et al. 1998; Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus. J Med Virol55:109–117 [CrossRef][PubMed]
    [Google Scholar]
  14. Kaye S., Howard M., Alabi A., Hansmann A., Whittle H., Schim van der Loeff M.. 2005; No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2. Clin Infect Dis40:876–878 [CrossRef][PubMed]
    [Google Scholar]
  15. Larkin M. A., Blackshields G., Brown N. P., Chenna R., McGettigan P. A., McWilliam H., Valentin F., Wallace I. M., Wilm A. et al. 2007; Clustal W and Clustal X version 2.0. Bioinformatics23:2947–2948 [CrossRef]
    [Google Scholar]
  16. Lole K. S., Bollinger R. C., Paranjape R. S., Gadkari D., Kulkarni S. S., Novak N. G., Ingersoll R., Sheppard H. W., Ray S. C.. 1999; Full-length human immunodeficiency virus type 1 genomes from subtype c-infected seroconverters in India, with evidence of intersubtype recombination. J Virol73:152–160[PubMed]
    [Google Scholar]
  17. Mohr E. L., Stapleton J. T.. 2009; GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat16:757–768 [CrossRef][PubMed]
    [Google Scholar]
  18. Muerhoff A. S., Simons J. N., Erker J. C., Desai S. M., Mushahwar I. K.. 1996; Identification of conserved nucleotide sequences within the GB virus C 5′-untranslated region: design of PCR primers for detection of viral RNA. J Virol Methods62:55–62 [CrossRef][PubMed]
    [Google Scholar]
  19. Muerhoff A. S., Smith D. B., Leary T. P., Erker J. C., Desai S. M., Mushahwar I. K.. 1997; Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol71:6501–6508[PubMed]
    [Google Scholar]
  20. Muerhoff A. S., Tillmann H. L., Manns M. P., Dawson G. J., Desai S. M.. 2003; GB virus C genotype determination in GB virus-C/HIV co-infected individuals. J Med Virol70:141–149 [CrossRef][PubMed]
    [Google Scholar]
  21. Muerhoff A. S., Leary T. P., Sathar M. A., Dawson G. J., Desai S. M.. 2005; African origin of GB virus C determined by phylogenetic analysis of a complete genotype 5 genome from South Africa. J Gen Virol86:1729–1735 [CrossRef][PubMed]
    [Google Scholar]
  22. Muerhoff A. S., Dawson G. J., Desai S. M.. 2006; A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5′-untranslated region sequences. J Med Virol78:105–111 [CrossRef][PubMed]
    [Google Scholar]
  23. Mukaide M., Mizokami M., Orito E., Ohba K., Nakano T., Ueda R., Hikiji K., Iino S., Shapiro S. et al. 1997; Three different GB virus C/hepatitis G virus genotypes. Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett407:51–58 [CrossRef][PubMed]
    [Google Scholar]
  24. Neibecker M., Schwarze-Zander C., Rockstroh J. K., Spengler U., Blackard J. T.. 2011; Evidence for extensive genotypic diversity and Recombination of GB virus C (GBV-C) in Germany. J Med Virol83:685–694 [CrossRef][PubMed]
    [Google Scholar]
  25. Okamoto H., Nakao H., Inoue T., Fukuda M., Kishimoto J., Iizuka H., Tsuda F., Miyakawa Y., Mayumi M.. 1997; The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol78:737–745 [CrossRef][PubMed]
    [Google Scholar]
  26. Schwarze-Zander C., Blackard J. T., Zheng H., Addo M. M., Lin W., Robbins G. K., Sherman K. E., Zdunek D., Hess G., Chung R.. AIDS Clinical Trial Group A5071 Study Team 2006; GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis194:410–419 [CrossRef][PubMed]
    [Google Scholar]
  27. Sherman K. E., Guedj J., Shata M. T., Blackard J. T., Rouster S. D., Castro M., Feinberg J., Sterling R. K., Goodman Z. et al. 2014; Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Sci Transl Med6:246ra98 [CrossRef][PubMed]
    [Google Scholar]
  28. Shimizu Y. K., Hijikata M., Kiyohara T., Kitamura Y., Yoshikura H.. 1999; Replication of GB virus C (hepatitis G virus) in interferon-resistant Daudi cells. J Virol73:8411–8414[PubMed]
    [Google Scholar]
  29. Stapleton J. T.. 2003; GB virus type C/Hepatitis G virus. Semin Liver Dis23:137–148 [CrossRef][PubMed]
    [Google Scholar]
  30. Tillmann H. L., Heiken H., Knapik-Botor A., Heringlake S., Ockenga J., Wilber J. C., Goergen B., Detmer J., McMorrow M. et al. 2001; Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med345:715–724 [CrossRef][PubMed]
    [Google Scholar]
  31. Tucker T. J., Smuts H., Eickhaus P., Robson S. C., Kirsch R. E.. 1999; Molecular characterization of the 5′ non-coding region of South African GBV-C/HGV isolates: major deletion and evidence for a fourth genotype. J Med Virol59:52–59 [CrossRef][PubMed]
    [Google Scholar]
  32. Tucker T. J., Smuts H. E.. 2000; GBV-C/HGV genotypes: proposed nomenclature for genotypes 1–5. J Med Virol62:82–83 [CrossRef][PubMed]
    [Google Scholar]
  33. Williams C. F., Klinzman D., Yamashita T. E., Xiang J., Polgreen P. M., Rinaldo C., Liu C., Phair J., Margolick J. B. et al. 2004; Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med350:981–990 [CrossRef][PubMed]
    [Google Scholar]
  34. Worobey M., Holmes E. C.. 2001; Homologous recombination in GB virus C/hepatitis G virus. Mol Biol Evol18:254–261 [CrossRef][PubMed]
    [Google Scholar]
  35. Xiang J., Wünschmann S., Schmidt W., Shao J., Stapleton J. T.. 2000; Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol74:9125–9133 [CrossRef][PubMed]
    [Google Scholar]
  36. Xiang J., Martinez-Smith C., Gale M., Chang Q., Labrecque D. R., Schmidt W. N., Stapleton J. T.. 2005; GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation. J Interferon Cytokine Res25:261–270 [CrossRef][PubMed]
    [Google Scholar]
  37. Xiang J., McLinden J. H., Chang Q., Kaufman T. M., Stapleton J. T.. 2006; An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A103:15570–15575 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000477
Loading
/content/journal/jgv/10.1099/jgv.0.000477
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error